IPO snapshot · 24 Jul 2026
Last verified 6 Oct 2026This page preserves the IPO terms and company information available at listing. Later share prices and financial results are not included.
- Valuation at IPO
- $263.7MBasic equity value after the offering
- Offer price at IPO
- $15.00Per share · USD
- Offering size
- $128.7MBase offering, before overallotment
- Listing date
- 24 Jul 2026First day of trading
Company overview
Scribe Therapeutics websiteThe company is a clinical-stage biotechnology company. It engineers purpose-built in vivo CRISPR technologies intended to extend healthy lifespan through disease prevention and durable therapeutic intervention.
- Company country
- United States
Offering details
USD · Base offering, before overallotment
- Exchange
- Nasdaq Global Market
- Ticker
- SCTX
- Shares offered
- 8,580,000
- Shares after offering
- 17,577,386
Valuation and offering basis
Basic equity valuation is the price per share multiplied by all shares outstanding immediately after the offering. It is different from enterprise value or fully diluted valuation. Offering size and gross proceeds exclude optional additional shares, fees and expenses. Ranges use the proposed price range; figures are rounded.